Home
LTC Pharmacies
Independent Pharmacies
Menu
About Us
LTC Pharmacies
Independent Pharmacies
Latest Updates
Top Issues
Find Your Legislators
Contact Us
Advocacy
Advocacy Tools
Building Relationships
Advocacy Do's and Don'ts
Action Alerts
Menu
Home
Share Your Story
Resources
My Profile
Tell a Friend
About Us
LTC Pharmacies
Independent Pharmacies
Top Issues
Find Your Legislators
Latest Updates
Contact Us
Take Action
Advocacy Tools
Building Relationships
Advocacy Do's and Don'ts
Advocacy
Advocacy Tools
Building Relationships
Advocacy Do's and Don'ts
Latest Updates
Sort By:
Pharmacy Type:
Independent
Long-Term Care
Topics:
ACA
Advocacy
AHCA
AMP
CMS
Controlled Substance
DIR Fees
dispensing fees
Drug Pricing
EPA
FDA
Federal Government
Federal Upper Limits
Florida
Gag Clauses
HHS
HHS Blueprint
Legislative Update
Legislator Visit
Long-Term Care
Managed Care
Medicaid
Medicare Advantage
Medicare Part B
Medicare Part D
NACDS
NCPA
Opioid
Phair Pricing Act
Pharmacy Visit
Provider Status
Senate HELP Committee
State Government
ThoughtSpot
Toolkit
TRICARE
Washington State
WSPA
Clear Filter
World without Rebates – AmerisourceBergen Ready to Support Transitioning Pharmaceutical Rebates to Point-of-Sale Discounts
May 20, 2019
AmerisourceBergen supports policies that lower out-of-pocket costs for patients and stands ready to support a transition to a patient-centered model with distributors serving as chargeback administrators for a January 1, 2020 start.
Full story
Good Neighbor Pharmacy Signs in support of NCPA's Pharmacy DIR Stakeholders Letter to Azar and Verma
Feb 01, 2019
AmerisourceBergen joined NCPA and other pharmacy stakeholders in signing a letter to CMS and HHS encouraging them to finalize proposals that address DIR fees in their recently proposed rule to lower out of pocket costs for seniors.
Full story
HHS Secretary Azar visits Spartan Pharmacy in Pittsburgh
Jan 04, 2019
Full story
Good Neighbor Pharmacy Signs in Support of HHS Blueprint
Jul 20, 2018
Good Neighbor Pharmacy joins more than 150 pharmacy stakeholders signing a letter to Secretary Azar, urging him to address pharmacy DIR fees in the administrations drug pricing blueprint.
Full story
© Copyright AmerisourceBergen Corporation. All Rights Reserved.